Provided by Tiger Fintech (Singapore) Pte. Ltd.

Harmony Biosciences Holdings, Inc.

29.54
+0.18000.61%
Volume:216.93K
Turnover:6.39M
Market Cap:1.70B
PE:11.77
High:29.71
Open:29.44
Low:28.92
Close:29.36
Loading ...

Harmony Biosciences to Report First Quarter 2025 Financial Results on May 6, 2025

Business Wire
·
Yesterday

Harmony Biosciences Is Maintained at Buy by UBS

Dow Jones
·
Yesterday

UBS Adjusts Price Target on Harmony Biosciences to $48 From $55, Maintains Buy Rating

MT Newswires Live
·
28 Apr

Harmony Biosciences price target lowered to $48 from $55 at UBS

TIPRANKS
·
28 Apr

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Apellis Pharmaceuticals (APLS) and Eton Pharmaceuticals (ETON)

TIPRANKS
·
28 Apr

BofA Cuts Price Target on Harmony Biosciences to $32 From $33

MT Newswires Live
·
21 Apr

JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?

Zacks
·
21 Apr

Positive Outlook for Harmony Biosciences’ ZYN002: Strong Phase 2 Data and Global Rights Support Buy Rating

TIPRANKS
·
09 Apr

Harmony Biosciences Price Target Maintained With a $50.00/Share by Needham

Dow Jones
·
08 Apr

Positive Outlook for Harmony Biosciences Holdings Based on Promising ZYN-002 Study Results

TIPRANKS
·
08 Apr

Harmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X Syndrome

Business Wire
·
08 Apr

Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory

Insider Monkey
·
04 Apr

Harmony Biosciences Appoints Ron Philip to Board

TIPRANKS
·
03 Apr

BRIEF-Harmony Biosciences Appoints Biotech Leader Ron Philip To Its Board Of Directors

Reuters
·
03 Apr

Harmony Biosciences Appoints Biotech Leader Ron Philip to Its Board of Directors

THOMSON REUTERS
·
03 Apr

Harmony Biosciences Appoints Biotech Leader Ron Philip to Its Board of Directors

Business Wire
·
03 Apr

Harmony Biosciences to Participate in 24th Annual Needham Virtual Healthcare Conference

Business Wire
·
26 Mar

BRIEF-Harmony Biosciences Names Adam Zaeske As Chief Commercial Officer

Reuters
·
24 Mar

Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of Commercial Growth as Its Portfolio Expands

THOMSON REUTERS
·
24 Mar

Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of Commercial Growth as Its Portfolio Expands

Business Wire
·
24 Mar